Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed May 13, 2024 · 10-Q · 43 days after period end · 0001640334-24-000757
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$2.48M | -$2.17M | -$1.97M | -$1.70M |
| EPS Diluted | -$0.78 | — | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 13, 2024 · 43 d after period end
